Orion Corporation has received Irish and Hungarian marketing authorisation for Bufomix Easyhaler®, an inhaled budesonide-formoterol combination product indicated for asthma and chronic obstructive ...
ORION CORPORATION STOCK EXCHANGE RELEASE 14 APRIL 2014 at 9:30 PM EEST Orion receives first marketing authorisations for Bufomix Easyhaler® product Orion Corporation has received Irish and Hungarian ...
ORION CORPORATION STOCK EXCHANGE RELEASE 14 APRIL 2014 at 9:30 PM EEST Orion receives first marketing authorisations for Bufomix Easyhaler® product Orion Corporation has received Irish and Hungarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results